The Greenwald Group Completes 14 Contemporary Single-Family

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
The Greenwald Group Completes 14 Contemporary Single-Family Homes

MIAMI, Nov. 04, 2016 (GLOBE NEWSWIRE) -- The Greenwald Group today announced the completion of 14 contemporary single-family homes in Miami-Dade’s most appealing residential neighborhoods.

“Today, there is a strong demand for modern, luxury single-family residences but a very limited number of suitable lots in Coconut Grove, Coral Gables and South Miami,” said Allen Greenwald, president and founder of Development Group. “We have carefully selected the locations for these 14 new homes, and with their beautiful design, modern features, and attractive pricing, we expect them to sell quickly.”

Drawing on the Greenwald Group’s decades of experience in residential real estate development, the 14 new homes include state-of-the-art appliances, luxury furnishings, pools and balconies on two-story models. Homes are priced from $2.3 million.

To design the new homes, the Greenwald team partnered with The Gershon Group, Inc., a family-owned South Florida firm that has specialized in commercial and residential design for the past 60 years.  Designers Scott and Rory Gershon worked closely with Greenwald to create contemporary residences designed to today’s lifestyles.

“I enjoy building fabulous new homes and helping them come to life,” said Andi Greenwald, who is known for her passion for detail. No aspect of her development projects, from the sidewalk pavers to the bathroom sinks, to the custom window treatments escapes her attention.

Back in 1960, Allen R. Greenwald started his own real estate business, which evolved into the Greenwald Group. In the past two decades, his daughter Andi and son Scott have focused on real estate development, including condominium conversions, new condominium projects and single-family homes in a wide range of prices.  “Many things have changed through the years, but real estate is still all about location,” Allen said. “I am confident that buyers will recognize the fact that these 14 new homes are in all the right locations.”

Andi Greenwald’s development resume includes six South Beach projects, two Miami Design Preservation League awards for excellence in restoration, and a key to the City of Miami Beach. Her other current projects include Bali, an elegant restoration of two South Beach buildings into four deluxe longhouses, a 15,000-square-foot waterfront mansion on North Bay Road, and a beautiful new construction home on the Miami Beach Golf Course.

Both the Greenwald and Gershon families have long been actively involved in the South Florida community. For example, Andi Greenwald and Rory Gershon are dedicated to rescuing cats and dogs, working closely with friends, neighbors and the Humane Society of Greater Miami to find adoptive homes.

Six years ago, they were renovating an older property on Miami Beach, and took on the responsibility of feeding a cat that had been abandoned after the prior owners had passed away. They soon realized there was a large population of cats living in the neighborhood, and began feeding them, paying for spaying and neutering services, and getting them into new homes. Today, they continue to lead the neighborhood’s pet rescue efforts, saving hundreds of kittens, puppies and adult cats and dogs. As Greenwald said, “We are big advocates of educating people about proper care of their pets.”

Link to photos: https://www.dropbox.com/sh/tprdo5tjzx6kw07/AA...auyFa?dl=0

Rogers & Cowan: Nicole Lewis 561-430-2613 nlewis@rogersandcowan.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 175

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 229

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 162

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 310

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 308

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 218

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

Orion Corporation's Manager Transactions Highlight Executive Moves

Updated Category News Views 133

Understanding Orion Corporation's Executive Transactions Orion Corporation, a prominent player in the global pharmaceutical industry, has recently disclosed significant transactions involving its management, shedding light on financial movements that reflect company growth and strategy. Key Details on Managerial Transactions Recently, Orion Corporation reported under the...

Continue Reading
Congressman Questions SEC's 'Digital Asset Security' Definition

Updated Category News Views 150

Congressman Ritchie Torres Questions SEC's Use of Terminology Representative Ritchie Torres, a Democratic representative from New York, has recently shared his concerns about the phrase "digital asset security" as used by the U.S. Securities and Exchange Commission (SEC). He’s particularly interested in the legal basis and origins of this term. Congressional Dialogue...

Continue Reading
Investigating Claims for StubHub Investors: Your Options

Updated Category News Views 173

Investigation of Claims on Behalf of StubHub Investors Faruqi & Faruqi, LLP, a prominent name in national securities law, is currently looking into potential claims related to StubHub Holdings, Inc. (NYSE: STUB). This initiative aims to assist investors who might have faced losses due to the misleading statements made about the company's financial performance during its...

Continue Reading
Sarepta Therapeutics Faces Class Action Amid Safety Concerns

Updated Category News Views 256

Introduction to Sarepta Therapeutics Sarepta Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative therapies for rare diseases, particularly those associated with genetic factors. The company is well-known for its gene therapy treatments and aims to revolutionize treatment options for patients with Duchenne muscular dystrophy and similar...

Continue Reading